open access
Surgical success in the management of retinal detachment secondary to a giant retinal tear
, 2, 2
Affiliations- Retina and Vitreous Surgeon, Grupo Oftalmológico Abdala-Figuerola AF, Barranquilla, Colombia
- Retina and Vitreous Fellow, Grupo Oftalmológico Abdala-Figuerola AF, Barranquilla, Colombia
open access
Abstract
Background: The purpose of this study was to describe anatomical and visual outcomes after scleral buckling, pars plana vitrectomy, and the use of silicone oil as a tamponade in the management of retinal detachment associated with giant retinal tears (GRT).
Material and methods: A retrospective descriptive chart review was conducted for cases with an initial presentation of rhegmatogenous retinal detachments associated with GRT. Patients underwent surgical management by a single surgeon and had follow-ups at least 12 months.
Results: We included 32 eyes of 32 patients. All eyes underwent 23G pars plana vitrectomy with scleral buckling and silicone oil as tamponade. Lensectomy was performed for all phakic eyes. Mean pre-operative best-corrected visual acuity (BCVA) was 20/800, and post-operative was 20/40 (20/20-LP). The mean follow-up was 18 months. Fourteen eyes (45%) had grade C proliferative vitreoretinopathy, and five eyes (16%) had GRT more than 180º. The primary reattachment rate was 93%, and the overall final anatomical success rate was 100%. Transient intraocular pressure (IOP) elevation was found in 6 (19%), and after silicone oil removal surgery, no patient required antihypertensive management.
Conclusion: High rates of anatomical success support the management of GRT-associated retinal detachment with scleral buckling, lensectomy, par plana vitrectomy, and the use of silicone oil as tamponade. Removal of silicone oil helps to avoid complications secondary to its emulsification, such as glaucoma and band keratopathy.
Abstract
Background: The purpose of this study was to describe anatomical and visual outcomes after scleral buckling, pars plana vitrectomy, and the use of silicone oil as a tamponade in the management of retinal detachment associated with giant retinal tears (GRT).
Material and methods: A retrospective descriptive chart review was conducted for cases with an initial presentation of rhegmatogenous retinal detachments associated with GRT. Patients underwent surgical management by a single surgeon and had follow-ups at least 12 months.
Results: We included 32 eyes of 32 patients. All eyes underwent 23G pars plana vitrectomy with scleral buckling and silicone oil as tamponade. Lensectomy was performed for all phakic eyes. Mean pre-operative best-corrected visual acuity (BCVA) was 20/800, and post-operative was 20/40 (20/20-LP). The mean follow-up was 18 months. Fourteen eyes (45%) had grade C proliferative vitreoretinopathy, and five eyes (16%) had GRT more than 180º. The primary reattachment rate was 93%, and the overall final anatomical success rate was 100%. Transient intraocular pressure (IOP) elevation was found in 6 (19%), and after silicone oil removal surgery, no patient required antihypertensive management.
Conclusion: High rates of anatomical success support the management of GRT-associated retinal detachment with scleral buckling, lensectomy, par plana vitrectomy, and the use of silicone oil as tamponade. Removal of silicone oil helps to avoid complications secondary to its emulsification, such as glaucoma and band keratopathy.
Keywords
giant retinal tear; retinal detachment; proliferative vitreoretinopathy; scleral buckling; pars plana vitrectomy
About this articleTitle
Surgical success in the management of retinal detachment secondary to a giant retinal tear
Journal
Issue
Vol 7 (2022): Continuous Publishing
Article type
Original paper
Pages
20-25
Published online
2022-03-17
Page views
4998
Article views/downloads
634
DOI
Bibliographic record
Ophthalmol J 2022;7:20-25.
Keywords
giant retinal tear
retinal detachment
proliferative vitreoretinopathy
scleral buckling
pars plana vitrectomy
Authors
Carlos Abdala-Caballero
Carlos Salgado-Cerrate
Nicolás Rivera-Valdivia
Pablo Cabal-López
Hiroshi Maeda-Yasunaga
References (20)- Ang GS, Townend J, Lois N. Epidemiology of giant retinal tears in the United Kingdom: the British Giant Retinal Tear Epidemiology Eye Study (BGEES). Invest Ophthalmol Vis Sci. 2010; 51(9): 4781–4787.
- Berrocal MH, Chenworth ML, Acaba LA. Management of Giant Retinal Tear Detachments. J Ophthalmic Vis Res. 2017; 12(1): 93–97.
- Shunmugam M, Ang GS, Lois N. Giant retinal tears. Surv Ophthalmol. 2014; 59(2): 192–216.
- Mehdizadeh M, Afarid M, Haqiqi MS. Risk factors for giant retinal tears. J Ophthalmic Vis Res. 2010; 5(4): 246–249.
- Rodriguez M, Lin J, Townsend JH, et al. Giant retinal tears: clinical features and outcomes of vitreoretinal surgery at a university teaching hospital (2011-2017). Clin Ophthalmol. 2018; 12: 2053–2058.
- Ambresin A, Wolfensberger TJ, Bovey EH. Management of giant retinal tears with vitrectomy, internal tamponade, and peripheral 360 degrees retinal photocoagulation. Retina. 2003; 23(5): 622–628.
- Hocaoglu M, Karacorlu M, Ersoz MG, et al. Vitrectomy with silicone oil tamponade for retinal detachment associated with giant retinal tears: Favourable outcomes without adjuvant scleral buckling. Acta Ophthalmol. 2019; 97(2): e271–e276.
- Rofail M, Lee LR. Perfluoro-n-octane as a postoperative vitreoretinal tamponade in the management of giant retinal tears. Retina. 2005; 25(7): 897–901.
- Gonzalez MA, Flynn HW, Smiddy WE, et al. Surgery for retinal detachment in patients with giant retinal tear: etiologies, management strategies, and outcomes. Ophthalmic Surg Lasers Imaging Retina. 2013; 44(3): 232–237.
- Kreiger A, Lewis H. Management of Giant Retinal Tears without Scleral Buckling. Use of radical dissection of the vitreous base and perfluoro-octane and intraocular tamponade. Ophthalmology. 1992; 99(4): 491–497.
- Kertes P, Wafapoor H, Peyman G, et al. The Management of Giant Retinal Tears Using Perfluoroperhydrophenanthrene. A multicenter case series. Vitreon Collaborative Study Group. Ophthalmology. 1997; 104(7): 1159–1165.
- Lee SY, Ong SG, Wong DWK, et al. Giant retinal tear management: an Asian experience. Eye (Lond). 2009; 23(3): 601–605.
- Dabour SA. The outcome of surgical management for giant retinal tear more than 180°. BMC Ophthalmol. 2014; 14: 86.
- Goezinne F, LA Heij EC, Berendschot TT, et al. Low redetachment rate due to encircling scleral buckle in giant retinal tears treated with vitrectomy and silicone oil. Retina. 2008; 28(3): 485–492.
- Verstraeten T, Williams GA, Chang S, et al. Lens-sparing vitrectomy with perfluorocarbon liquid for the primary treatment of giant retinal tears. Ophthalmology. 1995; 102(1): 17–20.
- Kunikata H, Abe T, Nishida K. Successful outcomes of 25- and 23-gauge vitrectomies for giant retinal tear detachments. Ophthalmic Surg Lasers Imaging. 2011; 42(6): 487–492.
- Randolph JC, Diaz RI, Sigler EJ, et al. 25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears. Graefes Arch Clin Exp Ophthalmol. 2016; 254(2): 253–257.
- Kumar V, Kumawat D, Bhari A, et al. wenty-five-gauge pars plana vitrectomy in complex retinal detachments associated with giant retinal tear. Retina. 2018; 38(4): 670–677.
- Banerjee PJ, Chandra A, Petrou P, et al. Silicone oil versus gas tamponade for giant retinal tear-associated fovea-sparing retinal detachment: a comparison of outcome. Eye (Lond). 2017; 31(9): 1302–1307.
- Moharram HM, Abdelhalim AS, Hamid MA, et al. Comparison Between Silicone Oil and Gas in Tamponading Giant Retinal Breaks. Clin Ophthalmol. 2020; 14: 127–132.